Home › NCT05967273
CirrhosisRx CDS System
Pragmatic Randomized Controlled Trial to Evaluate the Effect of CirrhosisRx, a Novel Clinical Decision Support System, on Guideline-adherence and Clinical Outcomes for Patients With Cirrhosis
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All adult (age ≥ 18 years) patients who have cirrhosis identified based on 1+ chronic liver disease and 1+ cirrhosis (or its complications) International Classification of Diseases, Revision 10 diagnosis codes OR mention of cirrhosis or portal hypertension (or their complications) in clinical documentation admitted at our institution. Exclusion Criteria: * Children (age \< 18 years) * patients who do not meet the cirrhosis definition criteria as noted above * ambulatory patients
About the study
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
What is being tested
- CirrhosisRx CDS (other)
Sponsor: University of California, San Francisco · Participants: 2,106 · Started: Jan 14, 2025
Contact the study team
- Jin Ge, MD, MBA · Phone: 415-502-8070
Official record on ClinicalTrials.gov — NCT05967273
Locations in the U.S.
| California | University of California San Francisco Medical Center, San Francisco |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.